About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Home > Market > Equity >
Company Snapshot
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Snapshot
Samrat Pharmachem Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code:
530125
NSE Symbol:
N.A
P/E :
0
ISIN Demat:
INE103E01016
Div & Yield %:
0
EPS :
0
Book Value:
220.67
Market Cap (Rs. Cr.):
79.70
Face Value :
10
Exchange
BSE
NSE
Stock Price Details
Last Price (₹)
250.00
Change
-2.10 (-0.81%)
Best Buy (₹)
0
Best Sell (₹)
0
Today's Range
247.05 - 259.00
52-Week Range
190.00 - 375.45
Beta (1 Year)
0.83
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Index Details
Corporate Announcements
Samrat Pharmachem to hold board meeting>
Samrat Pharmachem to convene AGM>
Samrat Pharmachem reports standalone net loss of Rs 2.04 crore in the March 2026 quarter>
Samrat Pharmachem reports standalone net loss of Rs 0.46 crore in the December 2025 quarter>
Corporate Details
Incorporation Year :
1992
Chairman :
Lalit Mehta
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs
Registered Office :
Samrat Pharmachem Ltd
Plot No A2/3445,
GIDC Phase IV,
Ankleshwar,
Gujarat - 393002,
Phone : 91-2646-220774,
Fax : 91-2646-251291
E-Mail :
contact@samratpharmachem.in
URL :
http://www.samratpharmachem.com
Investor Returns
Period
Date
Price(
₹
)
Returns (%)
1Week
15-Jul-2026
249.05
3.57
1Month
22-Jun-2026
200.60
28.59
3Month
22-Apr-2026
223.15
15.59
6Month
22-Jan-2026
211.90
21.73
1Year
22-Jul-2025
370.00
-30.28
Mutual Funds Holding
Scheme Name
% Holding
Market Value (₹.Cr)
No Data Found
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs
Company
Last Price(
₹
)
Change(%)
52Week High(
₹
)
52Week Low(
₹
)
Market Cap(
₹
)
Divis Laboratories Ltd
7,386.75
0.77
7,437.65
5,637.50
196,095.00
Acutaas Chemicals Ltd
3,667.50
-0.21
3,735.00
1,126.00
30,026.23
Neuland Laboratories Ltd
18,497.90
-2.09
20,072.00
11,500.00
23,732.60
Jubilant Pharmova Ltd
993.10
-0.24
1,250.00
783.75
15,820.08
Gujarat Themis Biosyn Ltd
351.75
-3.14
479.45
225.75
3,832.85